251 related articles for article (PubMed ID: 30853960)
21. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
22. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996
[TBL] [Abstract][Full Text] [Related]
23. Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2.
Guo Q; Bedford MT; Fast W
Mol Biosyst; 2011 Jul; 7(7):2286-95. PubMed ID: 21584310
[TBL] [Abstract][Full Text] [Related]
24. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
[TBL] [Abstract][Full Text] [Related]
25. Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4.
Gajendran C; Fukui S; Sadhu NM; Zainuddin M; Rajagopal S; Gosu R; Gutch S; Fukui S; Sheehy CE; Chu L; Vishwakarma S; Jeyaraj DA; Hallur G; Wagner DD; Sivanandhan D
Sci Rep; 2023 Feb; 13(1):3189. PubMed ID: 36823444
[TBL] [Abstract][Full Text] [Related]
26. PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease.
Liu X; Arfman T; Wichapong K; Reutelingsperger CPM; Voorberg J; Nicolaes GAF
J Thromb Haemost; 2021 Jul; 19(7):1607-1617. PubMed ID: 33773016
[TBL] [Abstract][Full Text] [Related]
27. Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues.
Thomassen MCLGD; Bouwens BRC; Wichapong K; Suylen DP; Bouwman FG; Hackeng TM; Koenen RR
J Thromb Haemost; 2023 May; 21(5):1214-1226. PubMed ID: 36716968
[TBL] [Abstract][Full Text] [Related]
28. Discovery of new inhibitor for the protein arginine deiminase type 4 (PAD4) by rational design of α-enolase-derived peptides.
Ahmad Nadzirin I; Chor ALT; Salleh AB; Rahman MBA; Tejo BA
Comput Biol Chem; 2021 Jun; 92():107487. PubMed ID: 33957477
[TBL] [Abstract][Full Text] [Related]
29. Peptidyl arginine deiminase 4 and its potential role in Alzheimer's disease.
Wang LL; Song YP; Mi JH; Ding ML
Med Hypotheses; 2021 Jan; 146():110466. PubMed ID: 33412502
[TBL] [Abstract][Full Text] [Related]
30. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
[TBL] [Abstract][Full Text] [Related]
31. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.
Bawadekar M; Gendron-Fitzpatrick A; Rebernick R; Shim D; Warner TF; Nicholas AP; Lundblad LK; Thompson PR; Shelef MA
Arthritis Res Ther; 2016 Jul; 18(1):173. PubMed ID: 27450561
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine deiminases 4 as a promising target in drug discovery.
Yang C; Dong ZZ; Zhang J; Teng D; Luo X; Li D; Zhou Y
Eur J Med Chem; 2021 Dec; 226():113840. PubMed ID: 34520958
[TBL] [Abstract][Full Text] [Related]
34. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
35. Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis.
Jonsson MK; Kantyka T; Falkowski K; Aliko A; Aga AB; Lillegraven S; Sexton J; Fevang BT; Mydel P; Haavardsholm EA
Scand J Rheumatol; 2020 Mar; 49(2):87-95. PubMed ID: 31544586
[No Abstract] [Full Text] [Related]
36. Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Baka Z; Barta P; Losonczy G; Krenács T; Pápay J; Szarka E; Sármay G; Babos F; Magyar A; Géher P; Buzás EI; Nagy G
Int Immunol; 2011 Jun; 23(6):405-14. PubMed ID: 21602177
[TBL] [Abstract][Full Text] [Related]
37. Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation.
Zheng Q; Osunsade A; David Y
Nat Commun; 2020 Jun; 11(1):3241. PubMed ID: 32591537
[TBL] [Abstract][Full Text] [Related]
38. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.
Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X
Neoplasia; 2022 Nov; 33():100835. PubMed ID: 36113195
[TBL] [Abstract][Full Text] [Related]
39. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
40. Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease.
Acharya NK; Nagele EP; Han M; Coretti NJ; DeMarshall C; Kosciuk MC; Boulos PA; Nagele RG
J Autoimmun; 2012 Jun; 38(4):369-80. PubMed ID: 22560840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
